Skip to main content
Caplight Logo









Kyron.bio

Kyron.bio

Private
ParisHealthcare & Life Scienceshttps://www.kyron.bio/

Last Round

Seed

May 28, 2025

Total Funding Raised

$7.46M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Kyron.bio is a biotechnology company that develops precision glycoengineering technology to optimize the efficacy, safety, and scalability of therapeutic proteins and antibody drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

glycan engineeringcell line engineeringglycoengineeringbiologic manufacturingbiomanufacturingtherapeutic proteinsantibody engineeringmonoclonal antibodiesbioprocessingglycosylationwet-lab biotechdrug developmentbiotech platformprotein optimizationbiopharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kyron.bio Comparables

Compare Kyron.bio with similar companies based on industry and business-model similarity.

Kyron.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GlycoDisplay ApS
83%
Augment Biologics
83%
FyoniBio GmbH
81%

Kyron.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 28, 2025

Kyron.bio Investors

Notable investors and investment history

Kyron.bio investors
InvestorRounds
Saras CapitalSeed
Verve VenturesSeed
HCVCSeed
Entrepreneurs FirstSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 251% MoM, reaching 5.1K.

  • Aug 18, 2026

    Grew 50% QoQ, from 8 to 12 employees.

Kyron.bio Filings

Explore SEC and related filing metadata, where available.

Kyron.bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kyron.bio's valuation, stock price, and market status.

Is Kyron.bio a public or private company?

Kyron.bio is a private company.

What is the current stock price of Kyron.bio?

Kyron.bio is a private company with no public stock price. No recent secondary market data is available.

How much is Kyron.bio worth (valuation)?

Valuation information for Kyron.bio is not publicly available.

Can I buy Kyron.bio stock?

Kyron.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kyron.bio's last funding round?

Kyron.bio's most recent funding round was Grant on May 28, 2025.

Who are the main investors in Kyron.bio?

Key investors in Kyron.bio include HCVC.

Will Kyron.bio IPO soon?

No public IPO plans have been announced for Kyron.bio.

How can I track Kyron.bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kyron.bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range11
Year Founded2022
Last FundingMay 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?